AbbVie News

AbbVie volunteers come together for fourth Week of Possibilities event

AbbVie recently launched its fourth annual Week of Possibilities, a volunteer function which will invite more than 6,000 employees in 50 companies to volunteer approximately 26,000 hours in their local communities.

AbbVie, Bristol-Myers Squibb team up to test smal-cell lung cancer treatment

AbbVie and Bristol-Myers Squibb are collaborating to evaluate the safety, tolerability and efficacy of AbbVie's investigational biomarker-specific antibody drug conjugate Rova-T paired with Bristol-Myers Squibb's Opdivo and Opdivo + Yervoy as a treatment for relapsed extensive-stage small cell lung cancer (SCLC).

Metro Business Network